|
New evidence-based guideline:
The Care of Women Requesting Abortion
By Ellie Lee
13/3/2000
A new evidence-based guideline, The Care of Women Requesting
Abortion, was published on 13 March 2000. The guideline,
produced by the Royal College of Obstetricians and Gynaecologists,
states that abortion services should 'provide high quality,
efficient, effective and comprehensive care that respects
the dignity, individuality and rights of women to exercise
personal choice over their treatment'. The document, which
is the result of more than a year of research and consultation
by an expert development group and has been funded and approved
by the Department of Health, is expected to influence the
way that abortion care is provided throughout Britain. It
aims to set standards of good practice that will be used
as the basis for the development of local protocols.
The introduction to the
guideline summary states: 'Induced abortion is one of the
most commonly performed gynaecological procedures in Great
Britain with around 180,000 terminations performed annually
in England and Wales and around 12, 000 in Scotland. At
least a third of British women will have had an abortion
by the time they reach the age of 45. Over 98% of induced
abortions in Britain are undertaken because the pregnancy
threatens the mental or physical health of the woman or
he children. This guideline has been developed in relation
to the care of women seeking abortion on such grounds. Two
recent RCOG publications have addressed legal, ethical and
service issues relating to the minority of abortions undertaken
because of fetal abnormality. Therefore, the recommendations
in this guideline do not address the special issues relating
to abortion for fetal abnormality.
The guideline development
group view induced abortion as a healthcare need and reiterate
the recommendation of the RCOG Working Party on Unplanned
Pregnancy (1991) that 'health authorities should accept
responsibility for the abortions needed by women resident
in their districts'. Although this guideline addresses
the discrete topic of abortion care, the development group
strongly support the concept that abortion services should
be provided as an integral part of broader sexual health
services. The concept of National Service Frameworks presented
in the White Paper 'The New NHS: Modern, Dependable'
is welcomed as an opportunity to place abortion, contraception
and genito-urinary medicine services together within a National
Service Framework for sexual and reproductive health'.
A summary of the guideline
recommendations is given below.
The guideline has been welcomed
by those who support women's choice in abortion. Ann Furedi,
speaking for Britain's largest provider of abortion services,
British Pregnancy Advisory Service, said: 'The development
of this guideline is a clear sign that medical profession,
policy makers and society at large are beginning to accept
abortion as part of essential reproductive health care.
Abortion may have been legal in Britain for 30 years but
it has yet to be recognised as entirely legitimate and is
often the subject of controversial debate. If the RCOG succeeds
in establishing these principles of care nationally it will
represent the 'coming of age' of abortion services'.
Pro-Choice Forum drew attention
the large amount of evidence provided in the guideline which
supports the claim that abortion is a safe medical procedure,
and the complications are uncommon. In particular, PCF noted
the confirmation in the guideline that abortion is not associated
with psychological trauma. Ellie Lee, co-ordinator of PCF
said: ' 'The RCOG guideline is a breath of fresh air. It
is very important and encouraging to see that the extent
and severity of negative feelings women experience after
abortion have been accurately presented, and compared with
the psychological effects of denied abortion. There has
been an unfortunate tendency on the part of media commentators
and other opinion formers to exaggerate the negative psychological
effects of abortion. Abortion is often talked about as a
'psychologically traumatic experience' or as 'inevitably
distressing and difficult for women to cope with'. Hopefully
the RCOG guideline will be taken seriously, and the psychological
effects of abortion will from now on be discussed in less
sensationalist terms'.
Predictably, representatives
of anti-choice organisations have expressed their opposition
to the guideline. Nuala Scarisbrick, speaking for the anti-abortion
organisation Life, said: 'It is deeply depressing that the
leading professional organisations should be calling for
easier abortions'.
Jack Scarisbrick, chairman
of Life, said, in contradiction to the vast amount of evidence
cited in the guideline: 'We can show that abortion is at
least three times more dangerous than childbirth. And most
women suffer depression and sadness afterwards'.
RCOG press release, 'Royal
College of Obstetricians and Gynaecologists Launches Abortion
Guidelines'. 13/3/2000
BPAS press release, 'BPAS
welcomes new national guidance on abortion care'. 13/3/2000
Pro-Choice Forum news release,
'RCOG findings on the psychological effects of abortion
are 'a breath of fresh air' say researchers'. 13/3/2000
'A New Right to Abortion',
Daily Mail, 11/3/2000
'Improve abortion services,
says Royal College Report', Independent on Sunday, 12/3/2000
'Abortion guidelines hailed
by campaigners', Guardian, 13/3/2000
The Care of Women
Requesting Induced Abortion
Guideline Summary
The recommendations within
this Guideline summary are extracted from the main Guideline
document. This summary is intended only to provide a quick
reference and is not intended to be considered without reference
to the main Guideline. The full guideline document is available
from the Royal College of Obstetricians and Gynaecologists
and it is strongly recommended that readers consult it to
understand the evidence base of the recommendations and
the background to the Guideline development.
The Care of Women Requesting
Induced Abortion is available from the RCOG bookshop,
27 Sussex Place, Regent's Park, London NW1 4RG, tel: 020
7772 6276 e-mail: bookshops@rcog.org.uk or via the website:
www.rcog.org.uk
£12 plus postage and packing
Summary of recommendations
The recommendations have
been graded according to the level of evidence upon which
they were based. The grading system used was formulated
by the Clinical Outcomes group (COG) and recommended by
the NHS Executive:
A Requires at
least one randomised controlled trial as part of a body
of literature of overall good quality and consistency addressing
the specific recommendation.
B Requires the
availability of well conducted clinical studies, but no
randomised clinical trials on the topic of the recommendation.
C Requires evidence
obtained from expert committee reports or opinions and/or
clinical experience of respected authorities. Indicates
an absence of directly applicable clinical studies of good
quality.
Good Practice Points
- Recommended
best practice based on the clinical experience of the guideline
development group
The strength of the evidence
on which each recommendation is based is shown. It is accepted
that in this grading system, the evidence itself is not
graded according to quality - although it is discussed narratively
in the text supporting each recommendation given in the
full guideline.
The validity of some grade
'C' recommendations and Good Practice Points may be questionable,
as they are not based on incontrovertible evidence. However,
the views of the Guideline Group combined with comments
from the extensive peer review suggest that the recommendations
with these gradings are acceptable to a wide body of expert
opinion, pending the results of future research.
Organisation of services:
- Abortion services
should have local strategies in place for providing information
to both women and healthcare professionals on the choices
available within the service and on routes of access to
the service.
- Any woman considering
undergoing induced abortion should have access to clinical
assessment.
- Appropriate
information and support should be available for those who
consider, but do not proceed to, abortion.
B The earlier in
pregnancy an abortion is performed, the lower the risk of
complications. Services should therefore offer arrangements
(e.g. a telephone referral system and direct access from
referral sources other than general practitioners) which
minimise delay.
C Service arrangements
should be such that:
· ideally, all women
requesting abortion are offered an assessment appointment
within five days of referral
· as a minimum standard,
all women requesting abortion are offered an assessment
appointment within two weeks of referral
· ideally, all woman
can undergo the abortion within seven days of the decision
to proceed being agreed
· as a minimum standard,
all women can undergo the abortion within two weeks of the
decision to proceed being agreed
· as a minimum standard,
no individual woman need wait longer than three weeks from
her initial referral to the time of her abortion.
- The assessment
appointment should be within clinic time dedicated to women
requesting abortion.
- In the absence
of specific medical, social or geographical contra-indications,
induced abortion should be managed on a day-case basis.
C An adequate number
of staffed inpatient beds must be available for those women
who are unsuitable for day-case care. In a typical abortion
service, up to 10% of women will require inpatient care.
- Access to services
should be ensured for women with special needs. For example,
as appropriate, special arrangements should be made for
non-English speaking women and a woman doctor should be
available.
- As far as possible,
women admitted for termination should be cared for separately
from other gynaecological patients.
- Women having second
trimester terminations by medical means must be cared for
by an appropriately experienced midwife or nurse. Ideally,
they should have the privacy of a single room.
Information for women
B Verbal advice
must be supported by accurate, impartial printed information
which the woman considering abortion can understand and
may take away and read before the procedure.
- Information
for women and professionals should emphasise the duty of
confidentiality by which, as for any form of health care,
all concerned with the provision of induced abortion are
bound.
- Professionals
providing abortion services should possess accurate knowledge
about possible complications and sequelae of abortion. This
will permit them to provide women with the information they
need in order to give genuinely informed consent.
Information on complications
and sequelae:
B Haemorrhage
at the time of abortion is rare. It complicates around 1.5/1000
abortions overall. The rate is lower for early abortions
(1.2/1000 at <1- weeks; 8.5/1000 at >20 weeks).
B Uterine perforation
at the time of surgical abortion is rare. The incidence
is of the order 1-4 per 1000. The rate is lower for abortions
performed early in pregnancy and performed by experienced
clinicians.
B Cervical
trauma: the rate of damage to the external cervical
os at the time of surgical abortion is no greater than 1%.
The rate is lower when abortions are performed early in
pregnancy and when they are performed by experienced clinicians.
B Failed abortion/ongoing
pregnancy: all methods of first trimester abortion carry
a risk of failure to terminate the pregnancy, thus necessitating
a further procedure. The rate for surgical abortion is around
2.3/1000 and for medical abortion around 6.0/1000.
B Post-abortion
infection: genital tract infection of varying degrees
of severity, including pelvic inflammatory disease, occurs
in up to 10% of cases. The risk is reduced when prophylactic
antibiotics are given or when lower genital tract infection
has been excluded by bacteriological screening.
B Breast cancer
risk: available evidence on an association between induced
abortion and breast cancer is inconclusive.
B Future reproductive
outcome: there are no proven associations between induced
abortion and subsequent infertility or preterm delivery.
B Psychological
sequelae: only a small minority of women experience
any long term adverse psychological sequelae after abortion.
Early distress, although common, is usually a continuation
of symptoms present before the abortion. Conversely, long-lasting
negative effects on both mothers and their children are
reported where abortion has been denied.
Pre abortion management
The abortion decision
C Clinicians
caring for women requesting abortion should try to identify
those patients who require more support in decision making
than can be provided in the routine clinic setting. Facilities
for additional support, including access to social services,
should be available.
Blood tests
C Pre-abortion
assessment should include:
- Measurement
of haemoglobin concentration
- Determination
of ABO and Rhesus blood groups with screening for red cell
antibodies
- (Screening
for other conditions such as haemoglobinopathies, HIV and
hepatitis B if indicated on clinical grounds)
B It is not cost-effective
to routinely cross-match women undergoing termination of
pregnancy.
Cervical cytology
- Assessment
prior to induced abortion may be viewed as an opportunity
to ascertain each woman's cervical cytology history. Women
who have not had a smear within the interval recommended
in their local programme may be offered a smear taken opportunistically.
- If a cervical
smear is taken opportunistically within the abortion service,
then mechanisms to ensure that the smear result is communicated
to the woman, acted on appropriately and recorded within
the local cervical cytology programme are essential.
Ultrasound scanning
C Ultrasound
scanning is not considered to be an essential prerequisite
of abortion in all cases. However, all units must have access
to scanning as it can be a necessary part of pre-abortion
assessment, particularly where the gestation is in doubt
or where extrauterine pregnancy is suspected.
C When ultrasound
scanning is undertaken, it should be done in a setting and
manner which are sensitive to the woman's situation. It
is inappropriate for pre-abortion scanning to be undertaken
in an antenatal department alongside women with wanted pregnancies.
Prevention of infective
complications
A Abortion care
should encompass a strategy for minimising the risk of post
abortion infective morbidity. Appropriate strategies include:
B antibiotic
prophylaxis, or screening for lower genital tract organisms
with treatment of positive cases.
· metronidazole 1g rectally
at the time of abortion
plus
· doxycycline 100mg twice
daily for 7 days, commencing post abortion
Abortion procedures
- As a minimum,
all services should be able to offer abortion by one
of the recommended methods for each gestation band.
B Ideally,
abortion services should be able to offer a choice of
recommended methods for relevant gestation bands.
Methods for women presenting
at under 7 weeks gestation
B Conventional
suction termination should be avoided at gestations of <7
weeks.
B Medical abortion,
using mifepristone plus prostaglandin, is a appropriate
method at gestations of <7 weeks.
B Early surgical
abortion using a rigorous published protocol may also be
an appropriate method at gestations of <7 weeks.
Recommended regimens for early
medical abortion
A For early medical
abortion, a dose of 200mg of mifepristone, in combination
with a prostaglandin is adequate.
A Misoprostol
(a prostaglandin E analogue), given vaginally is
a cost-effective alternative for all abortion procedures
for which the E analogue, gemeprost is conventionally
used (early medical abortion, cervical priming, mid-trimester
medical abortion).
Published regimens for early
medical abortion:
· mifepristone
600mg orally followed 36-48 hours later by Gemeprost 1mg
vaginally (mifepristone data sheet)
· >*mifepristone 200mg
orally followed 36-48 hours later by misoprostol 800µ>g
(4x200µ>g tabs) vaginally
· >*mifepristone 200mg
orally followed 36 hours later by Gemeprost 0.5mg vaginally
* Regimens are unlicensed
as described above
Methods for women presenting
between 7-15 weeks gestation
A Medical abortion
using the regimes described above continues to be an appropriate
method for women in the 7-9 week gestational band.
B Conventional
suction termination is an appropriate method at gestations
of 7-15 weeks, though individual practitioners may prefer
to offer medical abortion at gestations above 12 weeks.
B Suction termination
may be safer under local anaesthesia than under general
anaesthesia. Consideration should be given to making this
option available.
B Cervical preparation
is beneficial prior to suction termination and should be
routine when the woman is aged under 18 years or at a gestation
of >10 weeks.
Published regimens for cervical
priming:
· Gemeprost 1mg
vaginally, 3 hours prior to surgery (Gemeprost data sheet)
· *misoprostol
400µg (2x200µg tabs) vaginally, 3 hours prior to surgery
· >Mifepristone (as
in data sheet)
* Regimens are unlicensed
as discussed above
B For women beyond
12 weeks gestation, second trimester abortion with mifepristone
followed by prostaglandin has been shown to be safe and
effective.
A For mid-trimester
medical abortion, a dose of 200mg mifepristone is adequate.
B Surgical evacuation
of the uterus is not required routinely following mid-trimester
medical abortion. It should only be undertaken if there
is clinical evidence that the abortion is incomplete.
Methods for women presenting
at greater than 15 weeks gestation
A Mid-trimester
abortion by dilatation & evacuation (D&E), preceded
by cervical preparation, is safe and effective when undertaken
by specialist practitioners with access to the necessary
instruments and who have a sufficiently large case-load
to maintain their skills.
B As an alternative
to D&E, services may prefer to offer medical abortion
using the regimens described below for women in this gestation
band.
Published prostaglandin
regimens include the following:
· Mifepristone
600mg orally, followed 36-48 hours later by Gemeprost 1mg
vaginally every 3 hours to a maximum of 5 pessaries.
· >*Mifepristone 200mg
orally, followed 36-48 hours later by misoprostol 800µ>g
vginally, then misoprostol 400µg orally, three hourly, to
a maximum of 4 oral doses.
· >*Mifepristone 200mg
orally, followed 36 hours later by Gemeprost 1mg vaginally
every 6 hours.
* Regimens are unlicensed
as discussed above
Managing complications of abortion
- Oxytocics are
effective in reducing intraoperative blood loss.
- In cases of suspected
uterine perforation laparoscopy is the investigation of
choice.
After care
B Anti-D IgG should
be given to all non-sensitised RhD negative women following
abortion, whether by surgical or medical methods and regardless
of gestational age.
- After an abortion,
women must be given a written account of the symptoms they
may experience and a list of those that would make urgent
medical consultation necessary. They should be given a 24
hour help-line telephone number to use if they feel worried
about pain, bleeding or high temperature. Urgent clinical
assessment, and emergency gynaecological admission, must
be available when necessary.
C A follow-up appointment
(either within the abortion service or with the referring
clinician) within two weeks of the procedure should be offered
to each patient following abortion.
C Referral for
further counselling should be available for the small minority
of women who experience long term post-abortion distress
(Risk factors are ambivalence before the abortion, lack
of a supportive partner, a psychiatric history or membership
of a cultural group that considers abortion wrong).
B Before she is
discharged following abortion, future contraception should
have been discussed with each patient and contraceptive
supplies should have been offered if required. The chosen
method of contraception should be initiated immediately
following abortion.
- On discharge,
each patient should be given a letter that gives sufficient
information about the procedure to allow another practitioner
elsewhere to deal with any complications.
B Sterilisation
can safely be performed at the time of induced abortion.
However combined procedures are associated with higher rates
of failure and of regret on the part of the woman.
A It is safe and
effective to insert an IUCD for contraceptive use immediately
following induced abortion.
|